Clinical trial
Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic…
NCT00384306 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00384306 |
|---|---|
| Title | Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease |
| Official title | Investigation of the Side Effects of Orally Administered Glucocorticoids. An Open Label Study to Investigate the Effects of Orally Administered Prednisolone on Bone Metabolism in Patients With COPD. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Collaborators | University of Cambridge |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | prednisolone |
| Enrollment | 9 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Oct 6, 2006 |
| Last update posted | Apr 16, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: